Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia

被引:21
|
作者
Parellada, Eduard [1 ]
Velligan, Dawn I. [2 ]
Emsley, Robin [3 ]
Kissling, Werner [4 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Psychiat, Clin Schizophrenia Program PEC, E-08036 Barcelona, Spain
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
[3] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, ZA-7500 Cape Town, South Africa
[4] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherap, D-81675 Munich, Germany
关键词
D O I
10.1155/2012/318535
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
    Correll, Christoph U.
    Kim, Edward
    Sliwa, Jennifer Kern
    Hamm, Wayne
    Gopal, Srihari
    Mathews, Maju
    Venkatasubramanian, Raja
    Saklad, Stephen R.
    CNS DRUGS, 2021, 35 (01) : 39 - 59
  • [42] Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia Practical Considerations
    Kverno, Karan
    Rozenberg, Ilya
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2021, 59 (07) : 7 - 12
  • [43] Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics
    Onitsuka, Toshiaki
    Okada, Tsuyoshi
    Hasegawa, Naomi
    Tsuboi, Takashi
    Iga, Jun-ichi
    Yasui-Furukori, Norio
    Yamada, Naoki
    Hori, Hikaru
    Muraoka, Hiroyuki
    Ohi, Kazutaka
    Ogasawara, Kazuyoshi
    Ochi, Shinichiro
    Takeshima, Masahiro
    Ichihashi, Kayo
    Fukumoto, Kentaro
    Iida, Hitoshi
    Yamada, Hisashi
    Furihata, Ryuji
    Makinodan, Manabu
    Takaesu, Yoshikazu
    Numata, Shusuke
    Komatsu, Hiroshi
    Hishimoto, Akitoyo
    Kido, Mikio
    Atake, Kiyokazu
    Yamagata, Hirotaka
    Kikuchi, Saya
    Hashimoto, Naoki
    Usami, Masahide
    Katsumoto, Eiichi
    Asami, Takeshi
    Kubota, Chika
    Matsumoto, Junya
    Miura, Kenichiro
    Hirano, Yoji
    Watanabe, Koichiro
    Inada, Ken
    Hashimoto, Ryota
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (04) : 365 - 368
  • [44] Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
    Kim, Borah
    Lee, Sang-Hyuk
    Choi, Tae Kyou
    Suh, ShinYoung
    Kim, Yong Woo
    Lee, EunHee
    Yook, Ki Hwan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05): : 1231 - 1235
  • [45] Delphi Panel on the Relationship Between Long-Acting Injectable Antipsychotics and Longer-Term Functional Recovery in First-Episode and Early-Phase Schizophrenia Patients
    Kane, John M.
    Yildirim, Murat
    Madera-McDonough, Jessica
    Arango, Celso
    Fagiolini, Andrea
    Gorwood, Philip
    Sahota, Navdeep
    Correll, Christoph U.
    CNS SPECTRUMS, 2023, 28 (02) : 253 - 253
  • [46] Long-acting injectable (LAI) antipsychotics in the long-term treatment of schizophrenia
    Fleischhacker, Wolfgang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 321 - 322
  • [47] Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
    Vasiliu, O.
    EUROPEAN PSYCHIATRY, 2022, 65 : S322 - S322
  • [48] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA: A 18 MONTHS STUDY
    Romero Guillena, S. L.
    Gotor, F.
    Plasencia Garcia de Diego, B. O.
    Navarro Pablo, R.
    Santamaria, O.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [49] Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic in first-episode schizophrenic patients
    Petric, D.
    Racki, V.
    Graovac, M.
    Kastelan, A.
    Grahovac, T.
    Vucic-Peitl, M.
    Franciskovic, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 150 - 151
  • [50] Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia
    Correll, Christoph U.
    Lauriello, John
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (04)